{
  "retracted": false,
  "timestamp": 1488326400000,
  "updates": [
    {
      "timestamp": 1585376072794,
      "identifier": {
        "doi": "10.1158/1078-0432.ccr-16-3089"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1158/1078-0432.ccr-15-2724"
  },
  "publisher": "American Association for Cancer Research (AACR)",
  "title": "Correction: PAK1 Is a Novel Therapeutic Target in Tyrosine Kinase Inhibitorâ€“Resistant Lung Adenocarcinoma Activated by the PI3K/AKT Signaling Regardless of EGFR Mutation"
}
